Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 213
Appendix F
Committee Biographies
Harold C. Sox, M.D., M.A.C.P. (Co-Chair), is the editor of Annals of In-
ternal Medicine. He graduated from Stanford University (B.S. in physics)
and Harvard Medical School and served as a medical intern and resident
at Massachusetts General Hospital. He spent 15 years on the faculty of
the Stanford University School of Medicine, where he was the chief of the
division of general internal medicine and director of ambulatory care at the
Palo Alto VA Medical Center. In 1988, he returned to Dartmouth where
he served for 13 years as Joseph M. Huber Professor and chair of the de-
partment of medicine before taking his present position with the American
College of Physicians. Dr. Sox was the President of the American College of
Physicians from 1998 to 1999. He chaired the U.S. Preventive Services Task
Force from 1990 to 1995, the Institute of Medicine Committee to Study
HIV Transmission through Blood Products, and the Institute of Medicine
Committee on Health Effects Associated with Exposures Experienced in
the Gulf War. He chaired the Medicare Coverage Advisory Committee of
the Center for Medicare Services from 1999 to 2003. He currently chairs
the National Advisory Committee for the Robert Wood Johnson Founda-
tion Physician Faculty Scholars Program and is a member of the Board of
Directors of the Foundation for Informed Medical Decision Making. He
was elected to the Institute of Medicine of the National Academies in 1993.
His books include Medical Decision Making, Common Diagnostic Tests:
Selection and Interpretation, and HIV and the Blood Supply: An Analysis
of Crisis Decision Making.
OCR for page 214
INITIAL NATIONAL PRIORITIES FOR CER
Sheldon Greenfield, M.D. (Co-Chair), an internationally recognized leader
in quality of care and health services research, is the Donald Bren Professor
of Medicine and executive director of the Health Policy Research Institute,
University of California at Irvine. Dr. Greenfield’s research has focused on
primary care outcomes, quality of chronic disease care, patient participa-
tion in care, and assessment of comorbidity. He was the 1995 recipient of
the PEW Health Professions Commission Award for lifetime achievement
in Primary Care Research. Dr. Greenfield is a recipient of the Glaser Award
of the Society of General Internal Medicine and the 1999 Novartis Global
Outcomes Leadership Award. Dr. Greenfield is the 2006 recipient of the
Founders Award by the American College of Medical Quality (ACMQ).
Dr Greenfield was elected to the Institute of Medicine (IOM) in 1996. He
chaired the IOM Committee on Guidance for Designing a National Health
Care Disparities Report, and was chair of the IOM Cancer Survivorship
Report. He was the chair of the National Diabetes Quality Improvement
Alliance. His current research focus is on performance assessment at the
individual physician level, heterogeneity of treatment effects, and quality
of chronic disease care for ethnic and racial minorities. He received his
undergraduate degree from Harvard College and his medical degree from
the University of Cincinnati College of Medicine.
Christine K. Cassel, M.D., M.A.C.P., is president and CEO of the American
Board of Internal Medicine (ABIM) and the ABIM Foundation, and an ex-
pert in geriatric medicine, bioethics and quality of care. Dr. Cassel, board
certified in internal medicine and geriatric medicine, was the first female
board chair of the ABIM and the first female president of the American Col-
lege of Physicians. She chaired influential Institute of Medicine reports on
end-of-life care and public health. In April 2009, Dr. Cassel was appointed
by President Obama to the President’s Advisory Council on Science and
Technology. She has also held leadership positions in academic medicine,
including the University of Chicago, Mount Sinai Medical Center in New
York City, and Oregon Health & Science University. An active scholar
and lecturer, Dr. Cassel is the author or coauthor of 14 books and more
than 150 journal articles on geriatric medicine, aging, bioethics and health
policy. Her most recent book is Medicare Matters: What Geriatric Medicine
Can Teach American Health Care.
Kay Dickersin, M.A., Ph.D., is Professor of Epidemiology at Johns Hop-
kins Bloomberg School of Public Health, and Director of the Center for
Clinical Trials. She is also the director of the U.S. Cochrane Center (USCC)
and is director of the Cochrane Eyes and Vision Group US Satellite. The
USCC supports Consumers United for Evidence-based Healthcare (CUE),
a partnership with health and consumer advocacy organizations, started
OCR for page 215
APPENDIX F
in 2003. Dr. Dickersin’s main research contributions have been in clinical
trials, systematic reviews, publication bias, trials registers, and the devel-
opment and utilization of methods for the evaluation of medical care and
its effectiveness. Dr. Dickersin currently is engaged in or has recently com-
pleted projects funded by the National Institutes of Health, the Agency for
Healthcare Research and Quality, Blue Shield California, the Cochrane Col-
laboration, and the Center for Medical Technology Policy. At the Institute
of Medicine (IOM), she has been a member of many committees, including
the Committee on Reviewing Evidence to Identify Highly Effective Clinical
Services. Dr. Dickersin received a Master’s Degree in zoology, specializing
in cell biology, from the University of California, Berkeley, and a Ph.D.
in epidemiology from Johns Hopkins University’s School of Hygiene and
Public Health. Among her honors, Kay served as president of the Society
for Clinical Trials (2008-2009) and has been elected to membership in the
American Epidemiology Society and the IOM.
Alan M. Garber, M.D., Ph.D., is the Henry J. Kaiser Jr. Professor and a
professor of medicine at Stanford, where he directs the Center for Health
Policy and the Center for Primary Care and Outcomes Research. He is a
staff physician at the Palo Alto VA and directs the Health Care Program of
the National Bureau of Economic Research (NBER). He is a member of the
Panel of Health Advisers of the Congressional Budget Office, the American
Society for Clinical Investigation, the Association of American Physicians,
and the Institute of Medicine of the National Academy of Sciences. He
served as the chair of the Medicare Evidence Development and Coverage
Advisory Committee (Centers for Medicare & Medicaid Services), as a
member of the National Advisory Council on Aging (National Institutes of
Health), and as a member of many committees of the National Institutes
of Health and of the National Academies. His work addresses methods for
improving health care delivery and financing, particularly for the elderly. It
encompasses technology evaluation, analysis of the causes of health expen-
diture growth, and health care productivity. A summa cum laude graduate
of Harvard College, he received his Ph.D. in economics from Harvard and
an M.D. with research honors from Stanford, and trained in medicine at
Brigham and Women’s Hospital.
Constantine Gatsonis, Ph.D., is professor of medical science (Biostatis-
tics) and founding director of the Center for Statistical Sciences at Brown
University. Dr. Gatsonis is a leading authority on the evaluation of diag-
nostic and screening tests and has extensive involvement in methodologic
research in medical technology assessment and in health services and
outcomes research. He is Group Statistician of the American College of
Radiology Imaging Network (ACRIN), a National Cancer Institute funded
OCR for page 216
INITIAL NATIONAL PRIORITIES FOR CER
collaborative group conducting multicenter studies of diagnostic imaging
and image-guided therapy for cancer. A major focus of the research publi-
cations and current interests of Dr. Gatsonis is on Bayesian inference and
its applications to problems in biostatistics, with emphasis on the evalu-
ation of diagnostic imaging and health services and outcomes research.
Dr. Gatsonis has served on the Institute of Medicine Immunization Safety
Review Committee, the National Academy of Sciences (NAS) Committee
on Identifying the Needs of the Forensic Sciences Community (co-chair),
the NAS Committee to Study Engineering Aviation Security Environments,
the NAS Committee on Applied and Theoretical Statistics, the Commis-
sion on Technology Assessment of the American College of Radiology,
the Research Development Committee of the Radiology Society of North
America, the HSDG Study Section of the Agency for Health Care Policy
Research review panels of the Center for Devices and Radiological Health
of the Food and Drug Administration, and technical expert panels for
Health Care Financing Administration/Centers for Medicare & Medicaid
Services. He is the founding editor in chief of Health Services and Out-
comes Research Methodology, an associate editor of the Annals of Ap-
plied Statistics, Bayesian Analysis, Statistics and Probability Letters, and
Clinical Trials and convenor of the Diagnostic and Screening Test Methods
Working Group, Cochrane Collaboration. Dr. Gatsonis was elected fellow
of the American Statistical Association and the Association for Health
Services Research. He received his BA in mathematics, magna cum laude,
from Princeton and his PhD in mathematical statistics from Cornell.
Gary L. Gottlieb, M.D., M.b.A., serves as president of Brigham and Wom-
en’s/Faulkner Hospitals, a position he has held since March 1, 2002. He is
a professor of psychiatry at the Harvard Medical School. Partners Health-
Care recruited Dr. Gottlieb to become the first chairman of Partners Psy-
chiatry in 1998 and he served in that capacity through 2005. In 2000, he
added the role of president of the North Shore Medical Center where he
served until early 2002. Prior to coming to Boston, Dr. Gottlieb spent 15
years in positions of increasing leadership in health care in Philadelphia.
In 1983, he arrived at the University of Pennsylvania as a Robert Wood
Johnson Foundation Clinical Scholar. Through that program, he earned
an M.B.A. with distinction in Health Care Administration from Penn’s
Wharton Graduate School of Business Administration. He credits the pro-
gram with building a foundation of interest in health policy, management,
and academic leadership. Dr. Gottlieb went on to establish Penn Medical
Center’s first program in geriatric psychiatry and developed it into a nation-
ally recognized research, training, and clinical program. Dr. Gottlieb rose
to become executive vice chair and interim chair of Penn’s Department of
Psychiatry and the Health System’s Associate Dean for Managed Care. In
OCR for page 217
APPENDIX F
1994, he became director and CEO of Friends Hospital in Philadelphia, the
nation’s oldest, independent, freestanding psychiatric hospital. In addition
to his noteworthy academic, clinical and management record, Dr. Gottlieb
has published extensively in geriatric psychiatry and health care policy.
He is a past president of the American Association of Geriatric Psychiatry.
Dr. Gottlieb also was a director of NASDAQ-traded OVID Technologies
from 1997 to 1998 and participated in its acquisition by Wolters Kluwer
Publishing. Dr. Gottlieb received his B.S. cum laude from the Rensselaer
Polytechnic Institute and his M.D. from the Albany Medical College of
Union University in a 6-year accelerated biomedical program. He completed
his internship and residency and served as Chief Resident at New York Uni-
versity/Bellevue Medical Center. Now, as a recognized community leader in
Boston, Dr. Gottlieb also focuses his attention on workforce development
and disparities in health care. He was appointed by Mayor Thomas Menino
as chairman of the Private Industry Council, the city’s workforce develop-
ment board, which partners with education, labor, higher education, the
community, and government to provide oversight and leadership to public
and private workforce development programs. In 2004-2005, he served
as co-chair of the Mayor’s Task Force to Eliminate Health Disparities. Dr.
Gottlieb is slated to become the president and CEO of Partners HealthCare
System in January 2010.
James A. Guest, J.D., became president and CEO of Consumers Union in
February 2001 after a long career in public service and the consumer inter-
est, including 21 years as chair of Consumers Union’s Board of Directors.
Consumers Union is the expert, independent, nonprofit organization that
publishes Consumer Reports magazine, ConsumerReports.org, Consumer
Reports on Health, and other special publications. Consumers Union oper-
ates the Consumer Reports Health Ratings Center, the Best Buy Drugs Pro-
gram, which was supported initially, in part, by a grant from the National
Library of Medicine, and other programs relating to health care quality and
safety for which it also may seek federal grants. Consumers Union has a
public policy and advocacy division which advocates for governmental and
marketplace policies in the consumer interest. Mr. Guest is a member of the
Institute of Medicine Roundtable on Evidence-Based Medicine, the Quality
Alliance Steering Committee, and the Lucian Leape Institute of the National
Patient Safety Foundation. He has spoken before various health stakeholder
groups including the Association of Academic Health Centers, America’s
Health Insurance Plans, the World Health Care Congress, the National
Business Group on Health, and others. Mr. Guest also serves as vice presi-
dent of Consumers International, a federation of more than 225 consumer
organizations from 115 countries that serves as the global campaigning
voice for consumers around the world. Mr. Guest’s public service career
OCR for page 218
INITIAL NATIONAL PRIORITIES FOR CER
spans more than three decades. After graduating from Amherst College,
studying economics at MIT as a Woodrow Wilson Fellow, and graduating
from Harvard Law School, he worked as a legislative assistant to Senator
Edward Kennedy. In the early 1970s, Mr. Guest moved to Vermont, where
he served as Banking and Insurance Commissioner, Secretary of State, and
Secretary of Development and Community Affairs. Over the past 20 years,
he has served as CEO of several service organizations and advocacy groups
including Planned Parenthood of Maryland, Handgun Control, Inc. and the
Center to Prevent Handgun Violence, and the American Pain Foundation, a
national consumer information, education, and advocacy organization for
pain prevention and management.
Mark Helfand, M.D., M.P.H., M.S., is a professor in the Departments of
Medicine and Medical Informatics and Clinical Epidemiology at Oregon
Health & Science University and a practicing physician at the Portland VA
Medical Center. He has directed the Oregon Evidence-based Practice Cen-
ter since 1997 and is also editor in chief of the journal Medical Decision
Making. Dr. Helfand received his A.B. and B.S. from Stanford University
and his M.D. and MPH from the University of Illinois School of Medicine.
He specialized in internal medicine at Stanford, where he also completed a
fellowship and earned an M.S. in health services research. Dr. Helfand has
been a leader in methods for comparative effectiveness research. From 1998
to 2002, Dr. Helfand led a team that helped the U.S. Preventive Services
Task Force prioritize topics and develop evidence-based guidelines. In the
area of comparative effectiveness, he was a founder of the Drug Effective-
ness Review Project (2003-2006) and, since 2004, has served as director of
the Scientific Resource Center for AHRQ’s Effective Health Care program.
In addition to AHRQ, Dr. Helfand’s work is funded by the Veterans Ad-
ministration, the National Library of Medicine, Consumers Union, and the
Society for Medical Decision Making.
Maria Carolina Hinestrosa, M.P.H.,∗ is the executive vice president for
Programs and Planning at the National Breast Cancer Coalition (NBCC),
and founder and former executive director of Nueva Vida, a support or-
ganization for Latinas with cancer. She is a breast cancer survivor, having
been diagnosed with this disease in 1994 and in 2000. In 2008, she was
diagnosed with a radiation-induced sarcoma, a consequence of her prior
breast cancer treatment. Ms. Hinestrosa chairs the Integration Panel of the
Department of Defense Breast Cancer Research Program, serves on the
National Advisory Council and on the Stakeholder Group of the Effective
*Deceased.
OCR for page 219
APPENDIX F
Health Care Program at the Agency for Healthcare Research and Qual-
ity; on the Roadmap and the Communications Groups of the Institute of
Medicine’s (IOM’s) Roundtable on Evidence-Based Medicine, and on the
Oversight Body of the Ethical Force of the American Medical Association,
among other national committees. She has served on the IOM’s committees
on Technologies for the Early Detection of Breast Cancer (Mammography
and Beyond) and Reauthorization of MQSA (Improving the Quality of
Breast Imaging Standards), as well as on the Breast Cancer Technical Panel
of the National Quality Forum, on the National Action Plan on Breast
Cancer and on the National Cancer Institute’s Central Institutional Review
Board. Ms. Hinestrosa is an economist from Universidad del Rosario in
Bogota, Colombia; obtained a masters degree in economics from Western
Illinois University as a Fulbright Scholar, and a Masters of Public Health
from the George Washington University in Washington, DC. Prior to her
service as a consumer advocate, she worked as a business economist and
strategic planner in Colombia and New Zealand.
George J. Isham, M.D., M.S., chief health officer and plan medical direc-
tor, is responsible for health promotion and disease prevention, research,
and health professionals’ education. He is also responsible for the health
dimension of HealthPartners’ strategic plan and is active in state and na-
tional health policy issues. As plan medical director, he is responsible for
quality and utilization management for HealthPartners Health Plan. He is
a founding board member of the Institute for Clinical Systems Improve-
ment, a collaborative of Twin Cities medical groups and health plans that
is implementing clinical practice guidelines in Minnesota. Dr. Isham is
currently a co-chair of a State of Minnesota Health Care Reform Task
Force that is working on defining episodes of care. Dr. Isham provides
leadership to other care delivery systems through service on the board of
directors for Presbyterian Health Services in Albuquerque, New Mexico
and the External Advisory board of the Marshfield Clinic in Marshfield,
Wisconsin. Dr. Isham is active nationally as a member of the board of
directors of the American’s Health Insurance Plans, the Alliance of Com-
munity Health Plans, the Accreditation Association for Ambulatory Care,
and Bridges to Excellence. He is past co-chair and current member of the
National Committee for Quality Assurance’s (NCQA) Committee on Per-
formance Measurement which oversees the Health Plan quality measure-
ment standards and currently chairs the NCQA’s committee on Physician
Recognition Programs. He is a member of the National Priority Partners
effort convened by the National Quality Forum, chairing the population
health workgroup of that effort. He has served on the Centers for Disease
Control and Prevention’s (CDC) Task Force on Community Preventive
Services, on the Agency for Healthcare Research and Quality’s Advisory
OCR for page 220
0 INITIAL NATIONAL PRIORITIES FOR CER
Board for the National Guideline Clearinghouse, and currently is a mem-
ber of the U.S. Task Force on Clinical Preventive Services. He currently
serves on the advisory board for the Institute for Clinical and Economic
Review at Harvard. Dr. Isham has served on the Institute of Medicine’s
(IOM) Board on Population Health and Public Health Practice and chaired
the IOM committees that authored the reports Priority Areas for National
Action: Transforming Health Care Quality and The State of the USA
Health Indicators. Dr. Isham currently chairs the IOM Roundtable on
Health Literacy. He was invited to present the IOM’s Rosenthal Lecture for
2005 on “Next Steps Toward Higher Quality Health Care.” In addition,
he has served on a number of committees, has presented to a number of
workshops, and has served as a reviewer of reports and workshop proceed-
ings. In 2003, Dr. Isham was appointed as a lifetime National Associate
of the National Academies of Science in recognition of his contributions
to the work of the IOM.
Arthur A. Levin, M.P.H., is co-founder and the director of the Center
for Medical Consumers, a New York City based nonprofit organization
committed to informed consumer and patient health care decision mak-
ing, patient safety, evidence-based, high-quality medicine and health care
system transparency. It receives no funding from the drug, device or health
care industry. Mr. Levin was a member of the Institute of Medicine’s (IOM)
Committee on the Quality of Health Care that published the To Err is Hu-
man and Crossing the Quality Chasm reports. He also served on a number
of other IOM committees, most recently one that released its report Know-
ing What Works in Health Care: A Roadmap for the Nation, published last
winter. He is a member of the IOM Board for Health Care Services. Mr.
Levin is co-chair of the National Committee for Quality Assurance Com-
mittee on Performance Measures and a member of the National Quality
Forum Consensus Standards Approval Committee (CSAC). Levin is also
on the Board of the Foundation for Informed Medical Decision Making,
dedicated to supporting patients and families in their health care decision
making. Levin has served as the consumer representative on the FDA’s
Drug Safety and Risk Management Advisory Committee (DSaRM). On
the health information and exchange technology front, Levin is on the
board of THINC, a not-for-profit regional health information organiza-
tion located in the mid-Hudson Valley and is a founding board member
of the public-private partnership coordinating statewide HIT development
and implementation, the New York State E-Health Collaborative (NYeC).
Levin earned his M.P.H. degree in health policy from Columbia Univer-
sity School of Public Health and a B.A. degree in philosophy from Reed
College.
OCR for page 221
APPENDIX F
JoAnn E. Manson, M.D., Dr.P.H., M.P.H., is professor of medicine and
the Elizabeth Fay Brigham Professor of Women’s Health at Harvard Medi-
cal School, chief of the Division of Preventive Medicine at Brigham and
Women’s Hospital (BWH), and co-director of the Connors Center for
Women’s Health and Gender Biology at BWH. An endocrinologist and
epidemiologist, Dr. Manson is actively involved in women’s health re-
search, including several large-scale clinical trials and observational studies
of cardiovascular disease (CVD), diabetes, and cancer. Her research has
focused on the role of reproductive and hormonal factors, lifestyle and
behavioral variables that influence chronic disease risk, health promotion
and research translation, clinical trial methodology, and novel plasma and
genetic markers as predictors of CVD, diabetes, and cancer. Dr. Manson is
Principal Investigator of the Boston center for the Women’s Health Initia-
tive (WHI), the CVD component of the Harvard Nurses’ Health Study, the
Women’s Antioxidant and Folic Acid Cardiovascular Trial, the Vitamin D
and Omega-3 Trial, and other studies. She has published more than 700
articles in medical and scientific journals. Dr. Manson is the recipient of
numerous awards, including the “Woman In Science Award” from the
American Medical Women’s Association, the Harvard College “Women’s
Professional Achievement Award,” the Bowditch Award for Excellence in
Public Health, the Postmenopausal Cardiovascular Health Research Award
from the North American Menopause Society, the International Menopause
Society’s Henry Burger Prize, and others. She is an elected member of the
Association of American Physicians, the American Epidemiological Society,
and an elected Fellow of the American Association for the Advancement
of Science, and she serves on a number of editorial and advisory boards,
including the Board of the North American Menopause Society and the Sci-
entific Advisory Board of the Harvard HealthLetter and Nutrition Action
HealthLetter. Dr. Manson received her A.B. from Harvard University, her
M.D. from Case Western Reserve University School of Medicine, and her
M.P.H. and Dr.P.H. from the Harvard School of Public Health. Researchers
at Brigham and Women’s Hospital and Harvard University apply for and
receive grants from the federal government and industry on health-related
issues, including comparative effectiveness.
Katie Maslow, M.S.W., graduated from Stanford and received her M.S.W.
degree from Howard University. She is the director for Policy Development
at the Alzheimer’s Association. Her various projects at the Association en-
compass project management and advocacy on the national level on many
aspects of Alzheimer’s and dementia care. She directed the Association’s
initiatives on managed care and co-directed its multisite demonstration
project, Chronic Care Networks for Alzheimer’s Disease. She also directed
the Association’s demonstration project on improving hospital care for
OCR for page 222
INITIAL NATIONAL PRIORITIES FOR CER
people with dementia, which included the development of training materials
for hospital nurses caring for this population in partnership with the John
A. Hartford Institute for Geriatric Nursing. She represented the Association
on the National Assisted Living Workgroup and is the primary author of
the Association’s Alzheimer’s Facts and Figures, 2008. Before joining the
Alzheimer’s Association, Ms. Maslow worked for 12 years at the U.S. Of-
fice of Technology Assessment, studying policy issues in aging, Alzheimer’s
disease, long-term care, end-of-life, and case management. Ms. Maslow’s
current employer, the Alzheimer’s Association, receives grants from the U.S.
Department of Justice, the U.S. Administration on Aging, the Centers for
Disease Control and Prevention, long-term care provider organizations,
and pharmaceutical and other private companies. Ms. Maslow has served
on numerous government and non-government advisory panels on aging,
Alzheimer’s disease, dementia, family caregiving, home care, assisted living,
nursing home care, and care coordination. She has served on the national
board of the American Society of Aging (ASA) and won the Society’s ASA
award in 2003. She is a member of the American Geriatrics Society, the
Gerontological Society of America, and the National Association of Social
Workers.
Mark b. McClellan, M.D., Ph.D., is currently the director of the Engelberg
Center for Health Care Reform, senior fellow in economic studies, and
Leonard D. Schaeffer Director’s Chair in Health Policy Studies at the
Brookings Institution in Washington, DC. Before joining Brookings he was
the administrator of the federal Centers for Medicare & Medicaid Services
and the commissioner of the U.S. Food and Drug Administration. He is an
internist and economist with an interest in developing innovative statisti-
cal methods for using observational data to estimate the effects of medical
interventions. His research studies have focused on the economic and policy
factors influencing medical treatment decisions and health outcomes; tech-
nological change in health care and its consequences for health and medical
expenditures; and the relationship between health and economic well-being.
He has previously served as a visiting scholar at the American Enterprise
Institute, a member of the National Academy of Sciences’ National Cancer
Policy Board, associate editor of the Journal of Health Economics, and co-
principal investigator of the Health and Retirement Study, a longitudinal
study of the health and economic well-being of older Americans. During
2001 and 2002 he served in the White House as a senior policy director
for health care and related economic issues. He has twice received the Ar-
row Award for Outstanding Research in Health Economics. He earned his
Ph.D. in economics from the Massachusetts Institute of Technology, his
M.D. from the Harvard-MIT Division of Health Sciences and Technology,
OCR for page 223
APPENDIX F
and completed a residency in internal medicine at Brigham and Women’s
Hospital.
Sally C. Morton, Ph.D., M.S., is vice president for Statistics and Epide-
miology at RTI International. RTI receives funding from the federal gov-
ernment, foundations, and industry for research on health-related issues,
including comparative effectiveness. Dr. Morton is the 2009 president of
the American Statistical Association (ASA) and a member of the National
Academy of Sciences Committee on National Statistics (CNSTAT). She
served as a member of the Institute of Medicine (IOM) Committee on
Reviewing Evidence to Identify Highly Effective Clinical Services. She does
not receive compensation for any professional activity. Dr. Morton is an
Adjunct Professor of Biostatistics at the UNC-Chapel Hill School of Public
Health, and is a fellow of the ASA and of the American Association for
the Advancement of Science (AAAS). She is a meta-analytic expert for the
RTI–University of North Carolina (UNC) Evidence-based Practice Center
(EPC), which receives funding from the Agency for Healthcare Research
and Quality (AHRQ). Her research focuses on synthesis in evidence-based
medicine, and surveys of vulnerable populations, and she has received of the
AHSR Article-of-the-Year Award, and the AAPOR Policy Impact Award.
Dr. Morton received a Ph.D. in statistics, an M.S. in operations research,
a B.S. in mathematical sciences from Stanford, and an M.Sc. in statistics
from the London School of Economics. Prior to joining RTI, Dr. Morton
was the chair in Statistics and head of the Statistics Group at the RAND
Corporation.
Neil R. Powe, M.D., M.P.H., M.b.A., is the Constance B. Wofsy Distin-
guished Professor and vice chair of medicine at the University of California
San Francisco and chief of the Medical Service at San Francisco General
Hospital. Until recently, he was the James F. Fries Distinguished Service
Professor in the Department of Medicine at the Johns Hopkins University
School of Medicine and Director of the Welch Center for Prevention, Epi-
demiology and Clinical Research, a multidisciplinary research and training
center at Johns Hopkins focused on clinical and population-based research.
He also was professor of epidemiology and health policy and management
at Hopkins’ Bloomberg School of Public Health and founding director of
the Johns Hopkins Evidence-based Practice Center. He has published over
300 articles on the prevention, diagnosis and treatment of diseases, value of
health care technologies, and the effectiveness of the health care system. His
major areas of interest and expertise are kidney and cardiovascular diseases,
effectiveness and outcomes research, and economic evaluations in health
care. He has studied physician decision making and other determinants
of use of medical practices including payers’ decisions about insurance
OCR for page 224
INITIAL NATIONAL PRIORITIES FOR CER
coverage for new medical technologies, the effect of financial incentives on
the use of technology, efficiency and outcomes in for-profit versus nonprofit
health care institutions, and the relation between hospital volume, technol-
ogy and outcomes. Dr. Powe receives major funding for his work from
the National Institutes of Health and the Centers for Disease Control and
Prevention. His work is also currently being supported by research grants
from the Foundation for Informed Medical Decision Making and other
charitable organizations. Among Dr. Powe’s many honors are member-
ship in the Institute of Medicine, the John M. Eisenberg National Award
for Career Achievement in Research from the Society of General Internal
Medicine and the Distinguished Educator Award from the Association of
Clinical Research Training.
Joe v. Selby, M.D., M.P.H., is the director of the Division of Research, Kai-
ser Permanente, Northern California. He conducts research in the areas of
cancer screening, diabetes outcomes and quality improvement research. He
is a family physician, clinical epidemiologist and health services researcher.
He also serves as lecturer in the Department of Epidemiology and Biosta-
tistics, University of California, San Francisco School of Medicine, and as
a Consulting Professor, Health Research and Policy, Stanford University
School of Medicine. Dr. Selby was a member of the Agency for Healthcare
Policy and Research study section for Health Care Quality and Effective-
ness from 1999 through 2003. He is past chair and a member of Kaiser
Permanente’s National Research Council and of the Governing Board of
the HMO Research Network. He was a commissioned officer in the Public
Health Service from 1976 to 1983 and received the Commissioned Officer’s
Award in 1981. Dr. Selby has authored or co-authored over 200 peer-re-
viewed scientific publications, as well as numerous editorials and book
chapters. His publications cover a spectrum of topics from colon cancer
screening and diabetes outcomes research to the delivery of primary care,
quality measurement and quality improvement. Dr. Selby’s current research
includes clinical comparative effectiveness studies in the areas of diabetes
and hypertension care, with funding from the Agency for Healthcare Re-
search and Quality, the National Heart, Lung, and Blood Institute, and the
Centers for Disease Control and Prevention. He also serves as the director
of a large research center in which a number of researchers apply for fund-
ing to conduct comparative effectiveness studies across a variety of clinical
and programmatic areas.
Lisa Simpson, M.b., b.Ch., M.P.H., FAAP, is director of the Child Policy
Research Center at Cincinnati Children’s Hospital Medical Center and a
professor of pediatrics in the Division of Health Policy and Clinical Effec-
tiveness, Department of Pediatrics, University of Cincinnati. Dr. Simpson,
OCR for page 225
APPENDIX F
a board-certified pediatrician, also serves as the national director for Child
Health Policy at the National Initiative for Children’s Healthcare Quality,
an education and research organization dedicated solely to improving the
quality of health care provided to children. A nationally recognized health
services and policy researcher, Dr. Simpson has led studies of the safety,
quality and effectiveness of care for children and adolescents, the role of
health information technology in improving care for children, disparities
in care for children and youth, the health policy response to childhood
obesity, and the role of policies in advancing child health at both state
and national levels. She was formerly the deputy director of the Agency
for Healthcare Research and Quality and the Maternal and Child Health
Director in Hawaii. Dr. Simpson earned her undergraduate and medical
degrees at Trinity College (Dublin, Ireland) and an M.P.H. at the Univer-
sity of Hawaii, and she completed a post-doctoral fellowship in health
services research and health policy at the University of California, San
Francisco. She is also an elected member of three organizations’ Board of
Directors, AcademyHealth, the Coalition for Health Services Research, and
the National eHealth Collaborative, as well as numerous other national
committees. She previously served on an Institute of Medicine Committee
on improving the evidence base for health care (2008) and has recently
been appointed by Governor Beshear to co-chair the Committee on Child
Health and Wellbeing of the Commonwealth of Kentucky’s Commission on
Philanthropy. She has received numerous awards including the Excellence
in Public Service Award from the American Academy of Pediatrics, the
Senior Executive Service Meritorious Presidential Rank Award, the Health
and Human Services Secretary’s Distinguished Service Award, and, most
recently, the 2007 Health Policy Researcher of the Year award from the
Health Policy Institute of Ohio.
Sean Tunis, M.D., M.Sc., is the founder and director of the Center for
Medical Technology Policy (CMTP) in San Francisco, where he works with
health care decision makers, experts and stakeholders to develop methods,
strategies and policies for comparative effectiveness research. CMTP re-
ceives support for this work from a number of foundations, government
grants, as well as health plans, life sciences companies, and medical profes-
sional societies. Through September 2005, Dr. Tunis was the director of the
Office of Clinical Standards and Quality and chief medical officer at the
Centers for Medicare & Medicaid Services (CMS). In this role, he had lead
responsibility for clinical policy and quality for the Medicare and Medicaid
programs, which provide health coverage to over 100 million U.S. citizens.
Dr. Tunis supervised the development of national coverage policies, quality
standards for Medicare and Medicaid providers, quality measurement and
public reporting initiatives, and the Quality Improvement Organization
OCR for page 226
INITIAL NATIONAL PRIORITIES FOR CER
program. As chief medical officer, Dr. Tunis served as the senior advisor to
the CMS Administrator on clinical and scientific policy. He also co-chaired
the CMS Council on Technology and Innovation. Dr. Tunis joined CMS in
2000 as the director of the Coverage and Analysis Group. Before joining
CMS, Dr. Tunis was a senior research scientist with the Technology As-
sessment Group, where his focus was on the design and implementation of
prospective comparative effectiveness trials and clinical registries. Dr. Tunis
also served as the director of the Health Program at the Congressional Of-
fice of Technology Assessment and as a health policy advisor to the U.S.
Senate Committee on Labor and Human Resources, where he participated
in policy development regarding pharmaceutical and device regulation. He
received a B.S. in biology and history of science from the Cornell University
School of Agriculture, and a medical degree and masters in health services
research from the Stanford University School of Medicine. Dr. Tunis did his
residency training at UCLA and the University of Maryland in Emergency
Medicine and Internal Medicine. He is board certified in Internal Medicine
and holds adjunct faculty positions at Johns Hopkins and Stanford Univer-
sity Schools of Medicine.
I. Steven udvarhelyi, M.D., M.Sc., is senior vice president and chief medical
officer for Independence Blue Cross and its affiliated companies (IBC). In
this role, Dr. Udvarhelyi has overall responsibility for medical management
programs and policies, provider contracting and provider relations, phar-
macy services, and informatics. Specific areas of responsibility in medical
management include utilization management, case management, disease
management, quality management, prevention and wellness, claim payment
policy, and member and provider appeals and grievances. In overseeing
informatics, Dr. Udvarhelyi is responsible for corporate-wide information
management and reporting activities. Dr. Udvarhelyi also has oversight
over IBC’s pharmacy benefit management subsidiary. Dr. Udvarhelyi is a
board-certified internist and has over 15 years of experience in the managed
care industry. He received an A.B. from Harvard College, an M.D. from
the Johns Hopkins University School of Medicine, and an M.S. in Health
Services Administration from the Harvard School of Public Health. Prior to
his career in the managed care and insurance industry, Dr. Udvarhelyi was
a faculty member at Harvard Medical School and has published numer-
ous articles on quality in health care. He currently serves on the Board of
Directors of the National Committee for Quality Assurance, the National
Council of Physician Executives of the Blue Cross Blue Shield Associa-
tion, and on the Chief Medical Officers Committee of America’s Health
Insurance Plans. He is also a member of the Institute of Medicine (IOM)
OCR for page 227
APPENDIX F
Roundtable on Evidence-Based Medicine, and has served on other IOM
committees in the past.
A. Eugene Washington, M.D., M.Sc., is executive vice chancellor and pro-
vost at the University of California, San Francisco (UCSF), where he is also
professor of gynecology, epidemiology, and health policy in the School of
Medicine. He has been a national leader in assessing medical technologies
and shaping health policy. He has published extensively in his major areas
of research, which include prenatal genetic testing, cervical cancer screening
and prevention, noncancerous uterine conditions management, quality of
health care, and racial/ethnic disparities in health outcomes. Dr. Washing-
ton co-founded UCSF’s Medical Effectiveness Research Center for Diverse
Populations in 1993 and served as the director from its establishment
through July 2005, was chair of the Department of Obstetrics, Gynecology,
and Reproductive Sciences from 1996 to 2004, and also co-founded the
UCSF-Stanford Evidence-based Practice Center and served as its first direc-
tor from 1997-2002. He is a member of the Institute of Medicine (IOM)
of the National Academy of Sciences, where he serves on the governing
Council of the IOM, and he also currently serves on the Scientific Manage-
ment Review Board of the National Institutes of Health.
James N. Weinstein, D.O., M.S., is the Dartmouth College Third Century
Professor and director of the Dartmouth Institute for Health Policy and
Clinical Practice, professor and chair, Department of Orthopedic Surgery,
Dartmouth Medical School, and vice chair, Board of Governors, Dart-
mouth-Hitchcock Medical Center, Lebanon, New Hampshire. He is an
internationally renowned spine surgeon and health services researcher. He
is a leader in advancing “informed choice” to ensure that patients receive
evidence-based, safe, effective, efficient and appropriate care. With Dr. John
Wennberg, he established the first-in-the-nation Center for Shared Decision-
Making. He also founded the multidisciplinary Spine Center, which has be-
come an international model for patient-centered health care delivery, using
patient-generated outcomes data to measure and inform clinical practice.
He has recently been appointed vice chair of the Dartmouth-Hitchcock
Board of Governors, with responsibility for oversight of operations for New
Hampshire’s only academic medical center, the largest supplier of health
services in Northern New England. Dr Weinstein serves on the Institute
of Medicine standing committee Social Security Administration Disability
Determination, and is on the National Institutes of Health Council for
NIAMS, and serves as a director for the American Board of Orthopaedic
Surgery.
OCR for page 228
